Flufenidone, a class 1.1 new drug of hainanhaiyao, is expected to obtain clinical approval in the second half of this year
-
Last Update: 2015-05-28
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
A person from Hainan Haiyao (000566 SZ) company said in a conference call held by a securities firm that the company's class 1.1 new drug, flufenidone, is expected to obtain clinical approval in the second half of this year, with a potential patient of about 200 million In February 2014, the company announced that Haikou pharmaceutical factory, a wholly-owned subsidiary of the company, cooperated with Central South University in the research and development of the national class 1.1 new drug, flufenidone bulk drug and capsule, successfully applied for clinical application in China and was accepted This marks that the company has made new progress in the field of innovative drugs, and has formally entered the field of liver disease Flufenidone is a class 1 new drug (not yet marketed at home and abroad) aiming at the treatment of organ fibrosis related indications It is mainly used to treat and prevent chronic viral hepatitis, alcoholic liver disease, obstructive and reflux nephropathy, diabetic nephropathy, etc Hainan Haiyao mainly produces and sells anti infective, gastrointestinal and anti-tumor drugs In terms of research and development, it mainly focuses on secondary generic drug research and development, and in recent years, it has gradually increased investment in class I new drugs.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
